ChengDu ShengNuo Biotec Co.,Ltd. (SHSE: 688117)
Health Care · Pharmaceuticals · CN
CN¥18.03
-2.86% today · -39.3% 1Y
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE: 688117) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $593.11M and employs 1,833 people.
Over the last twelve months the share price has lost 39.3%, trading between 17.36 and 33.21.
Tweenvest scores ChengDu ShengNuo Biotec Co.,Ltd. across four factors: quality 68/100, value 87/100, growth 63/100, dividend 41/100. Its strongest factor is value.
688117 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $593.11M
- Revenue (TTM)
- $134.13M
- P/E
- 19.49
- EPS
- 0.93
- Dividend yield
- 1.39%
- Beta (5Y)
- 0.58
- 52-week high
- CN¥33.21
- 52-week low
- CN¥17.36
- Avg volume (3M)
- —
- Shares outstanding
- 220.34M
- Employees
- 1,833
- Next earnings
- —
About ChengDu ShengNuo Biotec Co.,Ltd.
ChengDu ShengNuo Biotec Co.,Ltd. focuses on the entire lifecycle of peptide pharmaceuticals, from initial research and development to manufacturing, and their subsequent domestic and international distribution. The company's product portfolio encompasses active polypeptide ingredients (APIs), solid dosage tablets, and a diverse range of injectable formats, including freeze-dried powders, small-volume solutions, pre-filled syringes, and specialized card-type injections. This enterprise was established in 2001 and conducts its operations from Chengdu, China.
- ISIN
- CNE1000051M8
- Founded
- 2001
- Listed since
- Jun 3, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanjing Hicin Pharmaceutical Co., Ltd.SZSE: 300584 | $600.53M | CN¥33.52 | +7.50% |
| Aquestive Therapeutics, Inc.NasdaqGM: AQST | $599.95M | $4.78 | +5.05% |
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $597.95M | CN¥5.30 | +1.92% |
| Beijing Tong Ren Tang Chinese Medicine Company LimitedSEHK: 3613 | $594.15M | HK$5.57 | +0.18% |
| Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676 | $592.53M | CN¥9.18 | +0.99% |
| Middle East Pharmaceutical Industries CompanySASE: 4016 | $589.61M | SR63.25 | +1.69% |
| Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020 | $589.45M | CN¥17.30 | +0.23% |
| Shanghai Xiao Fang Pharmaceutical Co.,Ltd.SHSE: 603207 | $586.98M | CN¥24.47 | +0.04% |
Figures last refreshed Oct 11, 2026.